|
Volumn 351, Issue , 2015, Pages
|
Excessive testing of adults with type 2 diabetes: Our fondness for treating numbers is harming patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HEMOGLOBIN A1C;
METFORMIN;
GLUCOSE BLOOD LEVEL;
ADULT;
BLOOD GLUCOSE MONITORING;
BLOOD PRESSURE REGULATION;
CLINICAL DECISION MAKING;
EDITORIAL;
EVIDENCE BASED MEDICINE;
GLYCEMIC CONTROL;
HUMAN;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT SAFETY;
POLYPHARMACY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
AGED;
BLOOD;
DIABETES MELLITUS, TYPE 2;
DISEASE COURSE;
FEMALE;
GLUCOSE BLOOD LEVEL;
MALE;
METABOLISM;
MIDDLE AGED;
PROGNOSIS;
ADULT;
AGED;
BLOOD GLUCOSE;
BLOOD GLUCOSE SELF-MONITORING;
DIABETES MELLITUS, TYPE 2;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PROGNOSIS;
|
EID: 84959069939
PISSN: 09598146
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.h6549 Document Type: Editorial |
Times cited : (5)
|
References (7)
|